For instance, inhibition of DAB2IP promoter methylation via knockdown of the DNA methyltransferase 3A (DNMT3A) reduced proliferation and survival of colorectal cancer cells by counteracting the activation of the MEK/ERK signaling pathway, possibly as a consequence of increased DAB2IP levels [59]. Here, DAB2IP is linked to colorectal cancer.